Anlon Healthcare, a Gujarat-based manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), is set to list on the exchanges this Wednesday. The Rs 121 crore IPO, which closed on August 29, was subscribed nearly 7 times overall. However, the grey market premium (GMP) stands at just 2%, indicating muted listing expectations.